NexImmune News

NexImmune | 4: Statement of changes in beneficial ownership of securities-Officer Jones Kristi

Jun 13 19:59 ET

NexImmune | 3: Initial statement of beneficial ownership of securities-Officer Marchio Albert N II

Apr 10 17:18 ET

NexImmune | 4: Statement of changes in beneficial ownership of securities-Director Roemer Alan S.

Nov 22, 2023 17:18 ET

NexImmune | 3: Initial statement of beneficial ownership of securities-Officer STOVER TIMOTHY

Sep 8, 2023 19:23 ET

NexImmune | 4: Statement of changes in beneficial ownership of securities-Director Verstandig Grant

Jul 7, 2023 16:24 ET

NexImmune | 4: Statement of changes in beneficial ownership of securities-Director Gandhi Leena

Jul 7, 2023 16:21 ET

NexImmune | 4: Statement of changes in beneficial ownership of securities-Director Yao Zhengbin

Jul 7, 2023 16:20 ET

NexImmune | 4: Statement of changes in beneficial ownership of securities-Director Roemer Alan S.

Jul 7, 2023 16:17 ET

NexImmune | 4: Statement of changes in beneficial ownership of securities-Director BARER SOL J

Jul 7, 2023 16:16 ET

NexImmune | 4: Statement of changes in beneficial ownership of securities-Director D'Angio Paul

Jul 7, 2023 16:16 ET

NexImmune | 4: Statement of changes in beneficial ownership of securities-Director Bertram Timothy

Jul 7, 2023 16:16 ET

NexImmune | SC 13D: Statement of acquisition of beneficial ownership by individuals-Sol J. Barer(9.17%)

Apr 7, 2023 16:16 ET

NexImmune | 4: Statement of changes in beneficial ownership of securities-Director Gandhi Leena

Apr 6, 2023 20:43 ET

NexImmune | 4: Statement of changes in beneficial ownership of securities-Director Roemer Alan S.

Apr 6, 2023 20:43 ET

NexImmune | 4: Statement of changes in beneficial ownership of securities-Director Verstandig Grant

Apr 6, 2023 20:42 ET

NexImmune | 4: Statement of changes in beneficial ownership of securities-Officer OELKE MATHIAS

Apr 6, 2023 20:41 ET

NexImmune | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Trainer John

Apr 6, 2023 20:41 ET

NexImmune | 4: Statement of changes in beneficial ownership of securities-Officer Jones Kristi

Apr 6, 2023 20:39 ET

NexImmune | 4: Statement of changes in beneficial ownership of securities-Director Yao Zhengbin

Apr 6, 2023 20:37 ET

NexImmune | 4: Statement of changes in beneficial ownership of securities-Director D'Angio Paul

Apr 6, 2023 20:36 ET